Key result
Complete device extraction and antimycobacterials successfully resolve rare BCG-related CIED infection.
Why the study?
Disseminated Mycobacterium bovis BCG infection is a recognized complication of intravesical BCG therapy for non-muscle-invasive bladder cancer, but cardiac implantable electronic device involvement is exceptionally rare.
Case Report (n=1)
This second published case of BCG-related CIED infection highlights that 18F-FDG PET/CT and PCR of explanted material can facilitate diagnosis in patients with persistent fever after intravesical BCG therapy when echocardiography is non-diagnostic.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rare post-BCG device infection risk; extends spectrum of disseminated BCG complications to cardiac devices.
Intravesical Bacillus Calmette-Guérin (BCG) is an established treatment for non-muscle-invasive bladder cancer. Although disseminated Mycobacterium bovis BCG infection is a recognized complication of BCG therapy, cardiac implantable electronic device (CIED) involvement is exceptionally rare. We report the second published case of BCG-related CIED infection. A 66-year-old man with an implantable cardioverter-defibrillator (ICD) presented with persistent fever following intravesical BCG therapy. Despite appropriate treatment of concomitant Serratia marcescens bacteremia, fever persisted. Echocardiography was non-diagnostic, whereas 18F-FDG PET/CT suggested device infection. Following complete device and lead extraction, polymerase chain reaction (PCR) of explanted material identified Mycobacterium tuberculosis complex, and cultures subsequently confirmed M. bovis BCG. Concurrent pulmonary involvement was microbiologically confirmed, and the clinical course was further complicated by immune thrombocytopenia. Antimycobacterial therapy resulted in clinical and radiological improvement, and a subcutaneous ICD was successfully implanted after infection control. BCG-related CIED infection should be considered in patients with persistent fever following intravesical BCG therapy, even when echocardiography is non-diagnostic. PET/CT and PCR of explanted device material may facilitate earlier diagnosis and guide management.
No takes yet. Share an insight, caveat, or question.
Vila‐Olives et al. (2026) conducted a case report in Mycobacterium bovis cardiac implantable electronic device (CIED) infection following intravesical Bacillus Calmette-Guérin (BCG) therapy (n=1). Complete device and lead extraction, antimycobacterial therapy, and subcutaneous ICD implantation was evaluated on Clinical and radiological improvement of BCG-related CIED infection. Complete device extraction and antimycobacterial therapy resolved Mycobacterium bovis BCG device infection in a 66-year-old man (n=1) identified via 18F-FDG PET/CT and PCR.
Synapse has enriched 10 related papers. Consider them for comparative context: